These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8819071)

  • 1. The role of the CD40 antigen on malignant B cells.
    Planken EV; Willemze R; Kluin-Nelemans JC
    Leuk Lymphoma; 1996 Jul; 22(3-4):229-35. PubMed ID: 8819071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the 'CD40 system'.
    Planken EV; Dijkstra NH; Willemze R; Kluin-Nelemans JC
    Leukemia; 1996 Mar; 10(3):488-93. PubMed ID: 8642867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies.
    Kedar R; Sabag O; Licthenstein M; Lorberboum-Galski H
    Cancer; 2012 Dec; 118(24):6089-104. PubMed ID: 22692727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific adoptive T-cell therapy for CD40+ B-cell malignancies.
    Schultze JL; Gribben JG; Nadler LM
    Curr Opin Oncol; 1998 Nov; 10(6):542-7. PubMed ID: 9818233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 and the effect of anti-CD40-binding on human multiple myeloma clonogenicity.
    Tong AW; Stone MJ
    Leuk Lymphoma; 1996 Mar; 21(1-2):1-8. PubMed ID: 8907262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-chain immunotoxins targeted to CD40 for the treatment of human B-lineage hematologic malignancies.
    Francisco JA; Siegall CB
    Leuk Lymphoma; 1998 Jul; 30(3-4):237-45. PubMed ID: 9713956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas.
    Pham LV; Tamayo AT; Yoshimura LC; Lo P; Terry N; Reid PS; Ford RJ
    Immunity; 2002 Jan; 16(1):37-50. PubMed ID: 11825564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.
    Xerri L; Bouabdallah R; Devilard E; Hassoun J; Stoppa AM; Birg F
    Br J Cancer; 1998 Jul; 78(2):225-32. PubMed ID: 9683298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
    van Kooten C; Rensink I; Aarden L; van Oers R
    Leukemia; 1993 Oct; 7(10):1576-84. PubMed ID: 8105156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dynamics of life and death of malignant lymphocytes.
    Younes A
    Curr Opin Oncol; 1999 Sep; 11(5):364-9. PubMed ID: 10505772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloma clonotypic B cells are hampered in their ability to undergo B-cell differentiation in vitro.
    Guikema JE; Vellenga E; Bakkus MH; Bos NA
    Br J Haematol; 2002 Oct; 119(1):54-61. PubMed ID: 12358903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and regulation of the IkappaB kinase in human B cells by CD40 signaling.
    Kosaka Y; Calderhead DM; Manning EM; Hambor JE; Black A; Geleziunas R; Marcu KB; Noelle RJ
    Eur J Immunol; 1999 Apr; 29(4):1353-62. PubMed ID: 10229103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IGM-induced growth arrest.
    Hornung M; Lindemann D; Kraus C; Peters A; Berberich I
    Eur J Immunol; 1998 Nov; 28(11):3812-23. PubMed ID: 9842924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growth.
    Lens SM; de Jong R; Hintzen RQ; Koopman G; van Lier RA; van Oers RH
    Leuk Lymphoma; 1995 Jun; 18(1-2):51-9. PubMed ID: 8580829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.
    Pellat-Deceunynck C; Amiot M; Robillard N; Wijdenes J; Bataille R
    Cancer Res; 1996 Apr; 56(8):1909-16. PubMed ID: 8620513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
    Jelinek DF; Darce JR
    Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-CD40 McAb induces CD40+ malignant B cell proliferation arrest and apoptosis].
    Zhou Z; Shi Q; Wang J; Pan J; Zhang X
    Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):237-9. PubMed ID: 11876986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation of precursor B-lineage acute lymphoblastic leukaemia by activating the CD40 antigen.
    Planken EV; Dijkstra NH; Bakkus M; Willemze R; Kluin-Nelemans JC
    Br J Haematol; 1996 Nov; 95(2):319-26. PubMed ID: 8904887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.